UPDATED Jun 23, 2026
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €4.79 | 4.1% | -23.5% | €128.8m | €12.30 | 16.9 | 94.4% | n/a | ||
ARGX | €813.00 | 7.6% | 66.5% | €49.5b | €862.27 | 38.7 | 21.2% | n/a | ||
UCB | €251.70 | 0.7% | 52.2% | €47.1b | €287.68 | 30.8 | 17.9% | 0.6% | ||
BIOS | €0.002 | 0% | -25.9% | €1.3m | n/a | -0.3 | n/a | n/a | ||
OXUR | €0.0032 | -20.0% | -90.9% | €301.6k | n/a | -0.1 | n/a | n/a | ||
TUB | €215.40 | -1.0% | 64.2% | €9.6b | €286.00 | 102.8 | n/a | 0.5% | ||
CYAD | €0.24 | -7.2% | -41.2% | €11.6m | n/a | 13.2 | n/a | n/a |